InfuSystems Holdings (INFU) Stock Price, Quote, News & History | Benzinga

SPY764.10+0.02%QQQ704.50+0.00%BTC/USD81,236.13−3.32%DIA528.16+0.05%GLD368.87−0.04%TLT81.72−0.02%

InfuSystems Holdings Inc (INFU) Stock Price, Quote, News & History

INFUAMEX

Trade with Public

Trade with Public

$14.14

0.090.64%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$14.11

Close

$14.14

Volume / Avg.

121.28K / 138.65K

Day Range

$13.90 - $14.41

52 Wk Range

7.29 - 14.28

Market Cap

-

P/E Ratio

35.13

Dividend Yield

-

Exchange

AMEX

RSI

-

Short Interest

-

Days to Cover

5.22

Recent InfuSystem Holdings Inc News

The Future of Medical Devices: Two Strong Buys You Can't Miss

The medical device market, a powerhouse sector, is projected to exceed $600 billion by 2025. This growth is fueled by a combination of factors, including an aging population, rising healthcare costs, and rapid

MarketBeat

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.

Lisa Levin

Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.

Lisa Levin

83 Biggest Movers From Yesterday

Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.

Lisa Levin

InfuSystem Inks Distribution Pact For Solo-Dex's Continuous Peripheral Nerve Block Catheters

InfuSystem Holdings Inc (NYSE: INFU) has

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

23.37M

Investing Cash Flow (TTM)

-8.23M

Financing Cash Flow (TTM)

-14.90M

Free Cash Flow (TTM)

12.55M

Capital Expenditure (TTM)

-10.82M

Net Change in Cash (TTM)

244.00K

Analyst Trends and Forecast

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$302.13M

PE Ratio (TTM)

35.13

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.05

PB Ratio (TTM)

4.73

Earnings Yield % (TTM)

2.85%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

11.46

Price / EBITDA (TTM)

11.14

Price / Free Cash Flow (TTM)

23.41

Book Value / Share

$2.97

Company Debt

Total Debt

$20.42M

LT Debt

$20.42M

LT Debt Issuance (TTM)

$29.16M

LT Debt Repayment (TTM)

-$34.98M

Total Cash

$964.00K

Debt to Equity

0.39

Issuance of Debt (TTM)

-$5.82M

Repayment of Debt (TTM)

-$34.98M